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Abstract
Candida albicans is the most common human fungal pathogen, causing infections that can be lethal in immunocompromised
patients. Although Saccharomyces cerevisiae has been used as a model for C. albicans, it lacks C. albicans’ diverse morphogenic
forms and is primarily non-pathogenic. Comprehensive genetic analyses that have been instrumental for determining gene
function in S. cerevisiae arehampered inC. albicans, duein part to limited resources to systematically assay phenotypes of loss-
of-function alleles. Here, we constructed and screened a library of 3633 tagged heterozygous transposon disruption mutants,
using them in a competitive growth assay to examine nutrient- and drug-dependent haploinsufficiency. We identified 269
genes that were haploinsufficient in four growth conditions, the majority of which were condition-specific. These screens
identified two new genes necessary for filamentous growth as well as ten genes that function in essential processes. We also
screened 57 chemically diverse compounds that more potently inhibited growth of C. albicans versus S. cerevisiae. For four of
these compounds, we examined the genetic basis of this differential inhibition. Notably, Sec7p was identified as the target of
brefeldin A in C. albicans screens, while S. cerevisiae screens with this compound failed to identify this target. We also
uncovered a new C. albicans-specific target,Tfp1p, for the synthetic compound 0136-0228. These results highlight the value of
haploinsufficiency screens directly in this pathogen for gene annotation and drug target identification.
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Introduction
Fungal species of the genus Candida generally live communally
on and in the human body, yet Candida infections can become
systemic and lethal in up to 60% of immunocompromised patients
[1,2]. C. albicans alone accounts for over 50% of all fungal
infections [3]. Furthermore, drug resistance to current therapies is
becoming increasingly prevalent [4], motivating research efforts to
understand the genetic basis of C. albicans’ pathogenesis and
uncover novel therapeutic targets.
The etiology of C. albicans is particularly complex, and our
understanding of this pathogen lags with respect to the model
organism Saccharomyces cerevisiae, which is often used as a proxy for
Candida species despite the fact that S. cerevisiae diverged from C. albicans
between 150–800 million years ago [5,6]. Notably, S. cerevisiae is rarely
pathogenic [7] and lacks the multiple morphogenic forms that define C.
albicans pathogenicity. C. albicans also exists as an obligate diploid and
lacks a traditional meiotic cycle [8]; as a result, many of the genetic
toolsdeveloped in S.cerevisiaeare not easilyapplied.Finally,only 58%of
predicted C. albicans proteins share an ortholog with S. cerevisiae [9,10],
underscoring the need for direct study of C. albicans.
An effective approach for such analyses would be to extend
high-throughput methodologies developed in S. cerevisiae to C.
albicans. For example, experimental multiplexing, in which a
genome-wide collection of deletion mutants is pooled and grown
competitively to determine the fitness of each mutant in an
experimental condition, has been particularly effective in S.
cerevisiae (reviewed in [11] and [12]). Strain tracking and
quantitation is enabled by the presence of unique DNA sequences,
or tags, introduced during the construction of each deletion
mutant [13]. To measure strain abundances in pooled growth
experiments, these strain-specific tags can be amplified and
hybridized to a microarray containing the tag complements, or
sequenced directly [14,15]. The S. cerevisiae deletion collection and
pooled phenotypic profiling have been invaluable for examining
gene function [14], genetic interactions [16], and for the
identification of drug targets and their mechanism of action
[17,18,19,20].
Strategies for large-scale mutant screening in C. albicans
include two studies using transposon mutagenesis to rapidly
generate large numbers of mutants [21,22], and a third study
using targeted deletions combined with a regulatable promoter
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insights, several factors have limited their widespread utility to
the C.albicansresearchcommunity. Forinstance,mutants in one
heterozygous disruption collection [22] are largely unse-
quenced, making predictions regarding its coverage difficult.
The homozygous transposon disruption collection [21], al-
though sequenced and archived as individual mutants, is
unavailable as an entire collection and its strains are not
tagged; thus experiments must be conducted individually. A
proprietary tagged deletion collection has been used to identify
novel antifungal targets [23,24,25,26], but the composition of
this collection is limited to 2868 strains that share homology to
genesessential in S. cerevisiae, otherfungi,and highereukaryotes.
Accordingly, a majority of C. albicans-specific genes are not
interrogated.
Our goal was to create an unbiased, open-access collection of
tagged C. albicans mutants useful for high-throughput experimental
multiplexing. We previously reported the creation of a pilot pool of
1290 tagged C. albicans mutants, using universal ‘‘TagModules’’ to
label transposons that were subsequently used to simultaneously
generate mutants and integrate a pair of DNA tags at the insertion
site [27]. Here, we describe the creation and validation of a
genome-wide C. albicans tagged transposon mutant collection,
using TagModule-based transposon mutagenesis to generate 4252
mutant strains, 3633 of which were detectable by microarray in a
pooled growth assay.
To demonstrate the utility of this collection, we investigated
nutrient-specific and drug-induced haploinsufficiency. By screen-
ing four different media conditions and 57 primarily synthetic
inhibitory compounds, we 1) identified genes functioning in core
or essential processes, 2) uncovered genes specific to growth in a
particular nutrient condition, and 3) demonstrated the utility of
this collection in antifungal screening to determine mechanism of
action of inhibitory compounds. This collection represents a
public, archived resource of tagged C. albicans mutants that can be
used to examine gene function either individually or multiplexed
in a pool.
Results
Construction and validation of a tagged C. albicans
collection
To circumvent the resource-intensive approach of generating
gene-specific deletion cassettes to knock out gene function, we used
tagged transposon mutagenesis to generate mutants. To incorpo-
rate tags into the transposon, we used 4280 Gateway-compatible
TagModules developed in a previous study as a source of
sequence-verified tags [27]. Each TagModule contains a pair of
DNA tags, an uptag and a downtag, flanked by common priming
sites for amplification of the tags to determine strain abundance.
These TagModules were transferred to a Gateway-compatible
transposon modified to contain the UAU1 selectable marker,
which allows heterozygous (Arg+) as well as homozygous
disruption mutants (Arg+, Ura+) to be generated [28]. The design
of the tagged transposons is shown in Figure 1A.
Following the approach of previous transposon mutagenesis
studies [21,22], these tagged transposons were used to mutagenize
a C. albicans genomic library in vitro. Following in vitro mutagenesis,
unique insertions were recovered in E. coli and sequenced
individually to determine the disrupted gene and its linked
TagModule (Figure 1B). We recovered a total of 21,468 usable
insertion events (see Methods S1 for criteria) representing 4827
unique genes (,78% of predicted open reading frames). 4239 of
these were successfully transformed (for criteria, see Methods) into
C. albicans via homologous recombination to create a uniquely
tagged, heterozygous disruption mutant (Table S2).
To examine the quality of our collection, we pooled the 4239
strains, amplified their tags, and hybridized them to an Affymetrix
TAG4 array (Figure 1C). At a zero timepoint (i.e., with no
competitive outgrowth), 3633 strains were detected (tag intensity
above 3X median background), with 619 strains falling below
background (Figure 2A). Failure to detect strains may result from
either a failure of the transformant to re-grow, or low abundance
prior to pooling. If the latter, these strains could assayed as a
separate subpool, or alternatively, detected using high-throughput
sequencing, which provides increased sensitivity [15]. After twenty
generations of growth in a pooled assay, biological replicates were
highly correlated (Figure 2B; R=0.98, p,10
216) and strains
showed low cross-reactivity with other features on the array; the
vast majority (12292/12686, or 97%) of unused tags on the array
had signal intensity below our cutoff of 3X background (Figure
S3). Thus, our tagged transposon mutants have robust and
reproducible performance in a pooled format.
Nutrient-dependent haploinsufficiency profiling of
tagged mutants
Genes that have a growth defect when reduced in copy number
from two to one (termed haploinsufficiency) are of interest for their
potential as drug targets [12]. We therefore sought to use the
pooled growth assay to define genome-wide haploinsufficiency in
C. albicans, particularly for C. albicans-specific processes and those
required for growth in hyphae-inducing conditions, a determinant
of virulence. We screened the C. albicans pool in four different
nutrient conditions at 30uC: i) rich YPD media, a standard
laboratory growth condition, ii) a synthetic media used for the
selection of transformants (SC), iii) minimal media, which has been
used to induce formation of pseudohyphae and consists of 2%
glucose and yeast nitrogen base (YNB), and iv) a low-nitrogen
minimal media (synthetic low ammonium dextrose, or SLAD),
which can induce pseudohyphal/hyphal growth in C. albicans.
To assess the effect of each gene disruption on growth in these
conditions, we tracked tag abundance for each of the detectable
Author Summary
Candida albicans is a normal inhabitant in our bodies, yet it
can become pathogenic and cause infections that range
from the superficial in healthy individuals to deadly in the
immunocompromised. Comprehensive genetic analysis of
C. albicans to identify mechanisms of virulence and new
treatment strategies has been hampered by limited,
publically accessible genomic resources. By combining
the principles of Saccharomyces cerevisiae strain tagging
with transposon mutagenesis to generate individually
tagged mutants, we created the first entirely public
resource that allows simultaneous measurement of strain
fitness of ,60% of the genome in a wide range of
experimental treatments. By identifying genes that confer
a fitness or growth defect when reduced in copy number,
we uncovered genes whose protein products represent
potential antifungal targets. Moreover, screening this
strain collection with chemical compounds allowed us to
identify anticandidal chemicals while concurrently gaining
insight into their cellular mechanism of action. This
resource, combined with straightforward screening meth-
odology, provides powerful tools to generate hypotheses
for functional annotation of the genome, and our results
highlight the value of direct versus model-based pathogen
studies.
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of growth with biological replicates. Following calculation of tag
abundance by hybridization of amplified tags to a microarray, we
fitted a linear regression to each strain’s abundance over a
timecourse and used the slope of the regression to measure strain
sensitivity. Based on Deutschbauer et al. [29], we defined a strain as
having a growth defect if its slope was ,0, p,0.05 (Table S3).
We found that regardless of media condition, similar propor-
tions of strains were haploinsufficient (Figure 3A). Overall, 145
(4%) strains were haploinsufficient in rich YPD, 105 (2.9%) in SC,
97 (2.7%) in YNB, and 140 (3.9%) in the low-nitrogen SLAD,
representing 269 (7.4%) unique genes. Only 9% (25) of these genes
were haploinsufficient in all conditions; the majority (55%) of these
269 genes were haploinsufficient in a single condition, suggestive
of condition-dependent haploinsufficiency (Figure 3B). This
observation suggests that a substantial portion of the C. albicans
genome may be amenable to haploinsufficiency profiling under
certain conditions.
Finally, comparing our haploinsufficiency profiling data in rich
media to that of S. cerevisiae [29], we found that while the overall
Figure 1. Construction of tagged transposon mutants in C. albicans. (A) A commercial Tn5 transposon was modified by inclusion of a
Gateway conversion cassette (with the ccdB selection gene and chloramphenicol resistance gene (Cm
R)), a kanamycin resistance gene (Kan
R), and the
UAU1 marker cassette at the multiple cloning site (MCS). A reaction with the modified Tn5, a pool of TagModules, and LR clonase induces
recombination at the att sites, placing the TagModule within the transposon mosaic ends (Tn5L and Tn5R). (B) To generate the heterozygous
disruption strains, multiple genomic DNA libraries were constructed and then mutagenized in vitro with the pool of tagged Tn5 transposons from (A).
Plasmids containing individual insertions were recovered from E. coli and sequenced (arrow) to determine the disrupted gene and its corresponding
tag. Results were sorted to maximize the unique gene insertions/tag pairs. Select insertions were amplified, followed by excision of the genomic DNA
containing the tagged transposon insertion. Transformation of these inserts into C. albicans was mediated by homology of the genomic sequence
flanking the transposon insertion, and integration was selected for based on the arginine prototrophy conferred by the Arg+ marker. Homologous
recombination results in a gene disruption with a tagged Tn5 transposon. (C) Screening methodology. Approximately equivalent numbers of tagged
transposon mutants are combined to create a tagged pool. Pools are then screened in diverse conditions, generally over 20 generations of
competitive growth with pools being harvested and diluted every 5 generations (5 g, 10 g, 15 g, 20 g). The genomic DNA is then extracted from the
pool and the uptags and downtags amplified separately using the common priming sites. After the pooled growth assay, the amplicons are then
hybridized to an Affymetrix TAG4 microarray to calculate tag intensity as a proxy for strain abundance.
doi:10.1371/journal.ppat.1001140.g001
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number of biological differences (Figure 3C). 48/145 (33%) of C.
albicans haploinsufficient genes in YPD had no S. cerevisiae ortholog.
Of those C. albicans genes that did have an ortholog, 26 are
orthologous to S. cerevisiae genes that were essential or haploinsuffi-
cient in YPD, and an additional 22 orthologs exhibited a growth
defect as a homozygous deletion in YPD. 49 (34%) orthologs had
no phenotype in YPD. Of the 269 haploinsufficient genes in C.
albicans, 97 (36%) had no S. cerevisiae ortholog. A second striking
difference between the S. cerevisiae and C. albicans haploinsufficient
gene sets is the number of transcription factors (TFs) haploinsuffi-
cient in C. albicans. Few transcription factors (excluding general
regulatory factors) were haploinsufficient in S. cerevisiae [29]. In
contrast, we identified seven TFs as haploinsufficient in YPD
(ZCF9, HAC1, LYS142, IRO1, SUA71, BDF1, RBF1), and a total of
13 in the complete haploinsufficient dataset (FGR17, SEF1, SUA72,
orf19.6623, orf19.5368, MSN4). Their functions range from iron
utilization to regulators of filamentous growth or stress response.
These findings highlight the need for direct study of C. albicans,a s
our assay uncovers novel phenotypes for orthologs as well as a
large number of C. albicans-specific genes.
To search for functional enrichment among the 25 genes
haploinsufficient in all conditions (Table S4), we used the Gene
Ontology Term Finder from the Candida Genome Database (http://
www.candidagenome.org/cgi-bin/GO/goTermFinder). These genes
were significantly enriched for the GO processes ‘‘translation’’
and GO functions ‘‘structural constituent of ribosome’’ and
‘‘structural molecule activity’’ (Table 1). We also observed genes
in this set that function in ‘‘core’’ cellular processes that are likely
to be either essential or necessary for growth regardless of
condition; for example, POL2 (DNA polymerase epsilon) and
orf19.736,w h o s eS. cerevisiae ortholog Sc-SRB8 is a subunit of RNA
polymerase II required for transcriptional regulation [30]. We
also identified a putative permease (orf19.3293), which may play a
role in nutrient sensing, two genes whose products protect against
oxidative stress (SOD3 and orf19.5553,b a s e do nS. cerevisiae
orthology), and a putative 59-monophosphate 59-nucleotidase,
ISN1, which is a fungal-specific gene whose S. cerevisiae ortholog
has been implicated in nucleotide scavenging [31]. Interestingly,
the S. cerevisiae orthologs for these four genes are not haploinsuffi-
cient, suggesting that S. cerevisiae and C. albicans have diverged with
respect to the relative importance of these genes for survival, or
that these genes are required at greater than heterozygote gene
doses in C. albicans.
Because the 25 genes that were haploinsufficient in all conditions (‘‘4
or more’’ subset) were enriched for genes involved in fundamental
cellular processes, we propose that the unverified genes in this set (those
which lack annotation, or those whose annotation has not been
confirmed experimentally) are also involved in core or essential
processes. As the GO enrichments for genes haploinsufficient in 3 or
more conditions (Table S5) were similar to the 4 or more subset
(Table 1),we expanded ourlist of‘‘core’’genes to include these genes as
well, for a total of 70 genes. Consistent with our observations in the 4 or
more subset, this 3 or more group included additional permeases
(MUP1 and orf19.5826) and two genes with predicted involvement in
oxidative stress response (TRR1 and POS5).
Assigning function to the core haploinsufficient set by
complementation
To ask if we could assign functions to this unverified ‘‘core’’
gene set, we selected 17 genes whose S. cerevisiae orthologs (or if an
ortholog was not found, the best BLAST hit was used) are
essential, so we could assess function by complementation testing
in S. cerevisiae. Although an imperfect test for C. albicans function
(and susceptible to false negatives), positive results strongly suggest
functional similarity.
We used two approaches to test for complementation. First, we
cloned these 17 C. albicans ORFs into a CEN/ARS vector with a
constitutive promoter and transformed them into the correspond-
ing S. cerevisiae heterozygous mutants (YKO). Sporulation of the
heterozygous deletion strain followed by selection for a haploid
knockout should yield no growth unless complemented by the
plasmid-borne C. albicans gene. To generate homozygous null S.
cerevisiae knockouts, we used the Magic Marker strains [32], which
use sequential selections to generate haploid deletion mutants. 6/
15 C. albicans ORFs with available corresponding Magic Marker
Figure 2. Validation of tagged C. albicans mutants via micro-
array hybridization. (A) Distribution of log2 tag intensities of the
4239 successfully transformed strains when pooled and tags amplified
and hybridized to a TAG4 array. Log2 of background intensity = ,6;
cutoff for detection was 3X background (log2 = ,7). 3633 strains were
detected with microarray signal intensity 3X above background. (B)
Biological replicates of C. albicans pool are highly correlated even when
using one tag per strain. Independent pools representing the 4239
heterozygous disruption strains were grown for 20 generations in YPD
+1% DMSO. Tags were amplified from each pool and hybridized to a
TAG4 array. Pearson correlation of unnormalized tags is indicated in the
upper left.
doi:10.1371/journal.ppat.1001140.g002
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tested as a control. Complementation was assessed based on a
significant increase in the number of colonies on the overexpres-
sion plate versus the vector-only plate (Figure 4A, Figure S5).
Second, we confirmed all negative Magic Marker results by tetrad
dissection (Figure 4B, Figure S5) and found that a total of 10/17 C.
albicans ORFs (two additional YKOs were available for this test) and
13/13 S. cerevisiae ORFs complemented their corresponding deletion
allele. In instances in which we observed complementation, segregation
of spore viability improved to 3:1or 4:0 (from2:2 incontrols), indicating
rescue of one or both of the haploid null spores. 3:1 segregants likely
result from incomplete segregation of the CEN/ARS-based plasmid,
which generally exists in one or more copies per cell, to all four spores.
Interestingly, we also observed two small-size spores in the case
orf19.7615/Sc-TRS31, indicating partial complementation. Based on
these results, we conclude that 10/17 C. albicans ORFs have the same
(or very similar) cellular roles as their S. cerevisiae ortholog and propose
the following changes to the description of these ORFs: a change of
Figure 3. Using the pooled growth assay to examine haploinsufficiency in C. albicans. (A) Pooled growth of 3633 strains was measured in
rich (YPD), semi-rich (SC), minimal (YNB), and low-nitrogen (SLAD) media. Samples were collected every 5 generations, after which tags were
amplified and hybridized to an array. A linear regression was fitted to the log2 of the normalized tag intensity values as a function of generation time.
Strains were categorized as haploinsufficient if the regression slope of their time course was statistically significantly less than 0 (adjusted p,0.05).
The total number of haploinsufficient strains was determined for each media condition. (B) The 269 haploinsufficient strains from the four media
conditions were separated into bins depending on whether they showed haploinsufficiency in one, two, three, or all media conditions. (C)
Comparison between C. albicans and S. cerevisiae haploinsufficient genes in rich media. Orthologs were retrieved for the 145 haploinsufficient genes
in YPD (http://www.candidagenome.org/), then compared against results from haploinsufficiency profiling of S. cerevisiae in YPD [29].
doi:10.1371/journal.ppat.1001140.g003
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function from the S. cerevisiae description (summarized in Table 2).
Confirmation of haploinsufficient phenotypes
Finally, to test whether this group of ‘‘core’’ genes tested via
complementation also represents essential C. albicans genes, we obtain-
ed GRACE strains [33] for 12/17 of the ‘‘core’’ group genes. Testing
the GRACE strains, which are conditional heterozygous knockouts
that can be converted (functionally) into homozygous knockout
mutants by repression of the second allele with doxycycline, served
two purposes: first, to determine whether these strains are viable as
homozygotes, and second, to validate that the phenotypes of our
mutants represent true positives by validating growth defects in an
alternative strain background. This is particularly relevant because it is
possible that synthetic effects with BWP179su r a c i lo rh i s t i d i n e
auxotrophies could contribute to the observed growth phenotypes.
We examined the growth of these 12 GRACE strains as well as
our 17 transposon-derived mutants in selective media. Overall,
after 15–20 generations of growth, the majority of our transposon
mutants recapitulated a growth defect as observed in the pooled
growth assay (Figure S4A). While the growth phenotypes of the
GRACE mutants were generally less severe (Figure S4B), we also
observed haploinsufficiency in 11/12 of these strains (defined as
,98% of BWP179s growth rate using the metric AvgG [34]). The
difference in the degree of haploinsufficiency could be the result of
either a ‘‘leakiness’’ in the tetracycline-regulated promoter of the
GRACE strains [33] causing production of additional gene
product and thereby alleviating the growth phenotype, or could
reflect some contribution of synthetic interactions with the
histidine and uridine auxotrophies mentioned above.
When the GRACE strains were grown in the presence of
100 mM doxycycline, 10/12 (FOL3 and TIF34 GRACE mutants
excepted) showed a severe to complete growth defect in all media
types, suggesting that they are essential in C. albicans (Figure S4C).
The fact that two strains were not essential under the GRACE test
but were able to complement their essential S. cerevisiae ortholog
could be the result of promoter leakiness, or could reflect that these
genes, while capable of performing a similar function as their S.
cerevisiae orthologs, are not essential in C. albicans.
Analysis of condition-dependent haploinsufficiency
We noted that haploinsufficiency in C. albicans is primarily
condition-dependent; 55% of the 269 haploinsufficient genes had
a growth defect in a single condition, and 19% of the 269 were
identified in only two conditions. Examining these genes, we found
two general categories. The first category, identified in rich media,
includes genes involved in oxidative metabolism, such as COX2,
NAD5, ABC1, KGD2, and (by annotation transfer from S. cerevisiae
orthologs) orf19.4204/Sc-PET123. We also observed haploinsuffi-
ciency in the C. albicans-specific alternative oxidases AOX1 and
AOX2 (GO:0016682, n=2, 1.4% vs 0% in the genome;
hypergeometric p=0.046), which are thought to function in
maintaining turnover of the TCA cycle, relieving saturation in
oxidative metabolism [35].
In reduced nutrient conditions, we observed a class of
haploinsufficient genes related to growth in low nitrogen. Genes
in this category, outlined in Table 3, were involved in 1) cell wall
maintenance (FAT1, SIM1, UPC2), 2) nutrient sensing/acquisition
(PUT4, JEN2, GPX2, MEU1, FUR1, SEF1), and 3) pseudohyphal
growth regulators (GRR1, FGR17, CPP1). orf19.1617, an uncate-
gorized gene in both C. albicans and S. cerevisiae (Sc-YDR282C), has
also been shown to have a filamentation defect [22]. Because these
categories encompass the roles of nutrient scavenging, initiation of
filamentation, and cell wall remodeling necessary to produce
hyphae, we asked if filamentation may be one mechanism by
which C. albicans thrives in low-nutrient conditions.
We investigated if these defects in growth rate correlate with
defects in filamentation by testing if the 77 genes necessary for
growth in the nutrient-limiting conditions (Table S6) manifested a
filamentous defect. Only 3/77 (BET2, SHE3, and RPS18) mutants
had a distinct filamentous defect on Spider agar (Figure 5), one
condition that elicits a filamentous phenotype. SHE3 and RPS18
had a completely smooth appearance with no peripheral filaments
compared to wild-type. BET2 had a smooth appearance with some
peripheral filaments. SHE3 has previously been shown to be
necessary for filamentous growth on Spider media [36]. The other
two genes (RPS18, a putative ribosomal protein, and BET2) have
not previously been implicated in a filamentous phenotype. BET29s
S. cerevisiae ortholog functions in vesicle transport, and in C. albicans
BET2 is regulated by Mig1p, a transcriptional repressor that
regulates carbon source utilization [37] and is downregulated in
hyphal growth [38] but upregulated in biofilms [39]. While we have
identified two new genes likely involved in filamentous growth, our
results suggest that genes required for growth in low-nutrient
conditions, asidentifiedinourSLAD-media screens, are, ingeneral,
different from those required for filamentation in Spider agar.
Table 1. GO analysis of genes haploinsufficient in 3 or more media types.
# of
conditions
GO
analysis GO ID Go term
Cluster
frequency
Background
frequency
Corrected
p-value Gene(s) annotated to the term
4 process 6412 translation 7/25 genes,
28.0%
374/6435
genes, 5.8%
0.03 RPS26A:RPS10:RPS1:RPL32:RPL43A:RPS30:TIF35
3+ process 51029 rRNA transport 4/70 genes,
5.7%
33/6435
genes, 0.5%
0.09 RPS26A:RPS10:NUP188:RPS15
3+ process 6407 rRNA export from
nucleus
4/70 genes,
5.7%
33/6435
genes, 0.5%
0.09 RPS26A:RPS10:NUP188:RPS15
3+ function 3735 structural constituent
of ribosome
9/70 genes,
12.9%
161/6435
genes, 2.5%
0.00 RPS26A:RPS10:RPL10:
RPS1:RPS21B:RPL32:
RPL43A:RPS30:RPS15
3+ function 5198 structural molecule
activity
10/70 genes,
14.3%
270/6435
genes, 4.2%
0.03 RPS26A:RPS10:RPL10:
RPS1:RPS21B:RPL32:RPL43A:RPS30:NUP188:RPS15
3+ function 146 microfilament motor
activity
2/70 genes,
2.9%
6/6435
genes, 0.1%
0.09 orf19.230:MYO2
doi:10.1371/journal.ppat.1001140.t001
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PLoS Pathogens | www.plospathogens.org 6 October 2010 | Volume 6 | Issue 10 | e1001140Figure 4. Representative results from complementation testing of ‘‘core’’ haploinsufficient strains. (A) Each C. albicans ORF was cloned
into an S. cerevisiae CEN/ARS expression vector with expression controlled by the constitutive GPD promoter (pAG416GPD, [60]). Overexpression
clones were then transformed into the corresponding S. cerevisiae strain containing a deletion of the essential ortholog and a Magic Marker cassette
[32]. The Magic Marker cassette allowed selection of null haploid mutants via sporulation followed by selection for matA cells containing a knockout.
4.5610
24 OD600 of sporulated culture was plated. Left, negative control (vector-only); center, complementation with C. albicans ORF; right, positive
control (complementation with corresponding S. cerevisiae ORF). TEM1 (upper panel) is an example of complementation of the C. albicans ORF; RXT3
(lower panel) does not complement. (B) Selected results from (A) were verified by tetrad dissection. For each box: left, negative control (vector-only);
center, positive control (complementation with corresponding S. cerevisiae ORF), and right, complementation with C. albicans ORF. The left box is an
example of full complementation, and on the right, a case of partial complementation. Tetrads were then replica-plated onto media containing 5-
fluoroorotic acid (5-FOA) or geneticin (G418) to confirm that the overexpression clone was the source of complementation.
doi:10.1371/journal.ppat.1001140.g004
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Briefly, ,500,000 colonies/pool was plated onto solid SLAD agar
plates and grown for 6 days at 37uC. By quantifying cells that had
invaded the agarose (pellet) and comparing them to the
proportions of cells that had not invaded the agar (supernatant),
we were able to determine if particular mutants were defective in
invasion. At a cutoff of 2-fold greater abundance in non-invaded
fraction (log2(supernatant/pellet) .2), we observed 341 mutants
that were invasion-defective (Table S8). As we previously
observed, there was little overlap (5/77) between strains that were
necessary for full growth in low nitrogen and those that had a
defect in agar invasion. However, when we compared the 243 S.
cerevisiae orthologs/best hits corresponding to these 341 mutants to
invasion-defective mutants of the pseudohyphal S. cerevisiae Sigma
1278B strain (O. Ryan, personal communication), we observed a
26% overlap (62/243), underscoring 1) the ability of our pooled
mutants to identify biologically consistent results, and 2) the
flexibility of the pooled assay to a solid-media format. Additional
experiments on solid media will provide a more detailed genome-
wide perspective on this key aspect of C. albicans physiology.
Table 2. Summary of individual strain testing of 17 ‘‘core’’ function genes & proposed annotations.
Magic Marker
complemented
Tetrad
dissection
complemented
#CUG
codons
C. albicans
gene
S. cerevisiae
ortholog
(gene) Verified? C. albicans description
no no 0 MYO2 MYO2 Verified Class V myosin
no yes 1 orf19.3293 TSC13 Verified* Protein similar to enoyl reductase for fatty acid elongation*
yes NA 4 orf19.6908 FOL3 Verified* Protein similar to dihydrofolate synthetase*
no yes (partial) 1 orf19.7615 TRS31 Verified* Protein similar to a TRAPP complex of the cis-Golgi*
NA no 3 POL2 POL2 Uncharacterized Protein described as DNA polymerase epsilon
no no 0 RPL10 RPL10 Uncharacterized Putative ribosomal protein
no yes (partial) 1 RPL32 RPL32 Verified* Protein component of the large (60S) ribosomal subunit*
no no 0 RPS15 RPS15 Uncharacterized Putative ribosomal protein
no no 5 RXT3 SCD5 Uncharacterized Predicted ORF in Assemblies 19, 20 and 21
no no 2 SGD1 SGD1 Uncharacterized Predicted ORF in Assemblies 19, 20 and 21
NA yes 0 SMX4 LSM3 Verified* Protein similar to Lsm3 involved in RNA processing and
decay*
yes yes 1 TEM1 TEM1 Verified* Protein similar to S. cerevisiae Tem1p*
yes NA 0 TIF34 TIF34 Verified Protein similar to eIF3i subunit of translation initiation factor
3*
no no 0 TIF35 TIF35 Uncharacterized Putative translation initiation factor
yes yes 0 TRR1 TRR1 Verified* Protein similar to thioredoxin reductase*
yes NA 8 TSR1 TSR1 Verified* Protein similar to 20S pre-rRNA processing unit*
yes NA 17 UGP1 UGP1 Verified Protein similar to UTP-glucose-1-phosphaturidyl transferase
*proposed.
doi:10.1371/journal.ppat.1001140.t002
Table 3. Categories of genes haploinsufficient in reduced-nutrient conditions.
Category Gene Description
cell wall maintenance FAT1 Predicted enzyme of sphingolipid biosynthesis
SIM1 Protein involved in cell wall maintenance
UPC2 Transcriptional regulator of ergosterol biosynthetic genes and sterol uptake
nutrient sensing/acquisition PUT4 Putative proline permease
JEN2 A carboxylic acid transporter that regulates uptake of malate and succinate, which are
additional sources of acetyl-CoA for the TCA cycle
GPX2 Putative glutathione peroxidase with antioxidant properties
MEU1 Putative enzyme in methionine salvage
FUR1 Enzyme of pyrimidine salvage
SEF1 Putative transcription factor regulating iron uptake
pseudohyphal growth regulators GRR1 Negative regulator of yeast-pseudohyphae switch
FGR17 Putative transcription factor regulating filamentous growth
CPP1 MAPK regulator of filamentous growth
doi:10.1371/journal.ppat.1001140.t003
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Haploinsufficiency profiling was developed in S. cerevisiae to
identify drugs that target gene products essential for growth, based
on the premise that lowering copy number of the target gene
sensitizes the corresponding heterozygous deletion strain to the
drug [40]. To select compounds for screening against the tagged C.
albicans mutants, we focused on those that inhibited C. albicans
growth more potently than S. cerevisiae. We reasoned that these
compounds would be more likely to have a different mechanism of
action in the two yeasts, e.g., by having distinct targets, different
mechanisms of influx/efflux, or different off-target effects. We
screened 1521 compounds (previously titrated to a concentration
that inhibits S. cerevisiae by ,10%, or IC10) against wild-type S.
cerevisiae and wild-type C. albicans and measured the ratio of
compound-treated growth to that of a control. While we found
that the majority of compounds inhibited C. albicans growth at
levels similar to S. cerevisiae’s, a number of compounds inhibited C.
albicans more severely (Figure 6A). For example, the top 40
compounds (highlighted in red) produced 20–90% greater
inhibition in C. albicans.
From this screen, we selected for titration and pooled growth
screening 67 readily available compounds that inhibited C. albicans
more strongly than S. cerevisiae in our initial screen (see Methods for
criteria). Comparing the dose response of these compounds for S.
cerevisiae and C. albicans, we observed that the compounds that
conferred differential growth inhibition fell into two classes of dose
response curves (representative curves are shown in Figure 6B,
Figure S6). The first class included those with parallel dose
response curves, suggestive of a compound that has the same
target in both yeasts but different cell permeability or residence
time. A second category included those in which the dose-response
curves had different slopes, suggestive of a different mechanism of
action or distinct secondary effects. Overall, these results from
screening a library of 1521 compounds against wild-type C. albicans
and S. cerevisiae suggest that certain compounds may have distinct
mechanism of action (e.g., a combination of primary and
secondary activities) in C. albicans.
To study the genetic basis of the differential action of certain
compounds in C. albicans and S. cerevisiae, we screened 57 of the 67
compounds at approximately an IC20 in the pooled growth assay
(chemical structures are shown in Figure S7; to demonstrate that
these 57 represented chemically diverse compounds, the distribu-
tion of their pair-wise similarities, based on Tanimoto scores, is
shown in Figure S8). We performed a 20-generation endpoint assay
(by analogy to the S. cerevisiae haploinsufficiency profiling) in which
the abundance of each strain in a compound-treated pool was
compared to its abundance in a set of DMSO-treated controls. To
identify drug-induced haploinsufficiency, a normalized z-score was
used to examine the response of each strain to a compound,
comparing the performance of a strain (proxied by tag intensity) in
the compound treatment to its performance in the no-drug controls
(Table S7). Positive z-scores indicate increasing sensitivity to the
treatment condition; strains with a high z-score were significantly
affected by the drug treatment and may be depleted of genes that
encode a cellular target. Of the 57 screens, we focused on 25 that
had a small number of significantly sensitive outliers, those most
likely to be representative of compounds that act through a single or
small number of targets. The remaining 32 compounds exerted
either widespread or few fitness defects in the pool. An overview of
the z-scores for these 25 compounds is shown in Figure 7A.
We found that the GTP exchange factor SEC7, which activates
formation of transport vesicles, was the most sensitive strain in
Figure 5. Few strains haploinsufficient in pooled growth have defects in filamentation. Strains defined from pooled screens as
haploinsufficient in reduced nutrient conditions (YNB or SLAD) media, but not haploinsufficient in rich media (YPD or SC) were grown individually on
agar media that induces filamentation (Spider media). Duplicates of control wild-type C. albicans strains BWP17 and parent strain SC5314 are in the
bottom right; strains with a filamentous defect are indicated with an arrow.
doi:10.1371/journal.ppat.1001140.g005
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In addition, analysis of the 30 most sensitive strains from the
nigericin screen in C. albicans showed GO enrichment of a number
of vesicle transport-related processes (e.g., Golgi vesicle transport
(GO:0048193), 20.7% (n=6) versus 2.4% in the genome,
hypergeometric p,0.008). As nigericin affects ion gradients across
lipid membranes (as opposed to having a direct protein target
[41]), we speculate that changes in membrane permeability, and
by extension intracompartmental pH (see below), interact
synthetically with defects in vesicle transport to cause a fitness
defect. Brefeldin A, whose protein target is widely considered to be
Sec7p [23] had a less pronounced effect on vesicle transport;
brefeldin A-sensitive strains were GO-enriched for function
‘‘GTPase regulator activity’’ (GO:0005085, 6.7% (n=2) versus
0.4% in the genome, hypergeometric p,0.07). Interestingly,
neither compound induced SEC7 haploinsufficiency in S. cerevisiae
(Figure 7B), even though brefeldin A has been shown to inactivate
S. cerevisiae Sec7p complexes in vitro [42]. These results 1) suggest
that S. cerevisiae has additional targets that become rate-limiting for
growth prior to the effects of inhibition of SEC7, and 2) confirm
the utility of our pool for validating C. albicans-specific targets.
Two synthetic, uncharacterized compounds, 1187–1561 and
0136–0228, also inhibited vesicle transport-related functions in C.
albicans (Figure 8A). We confirmed sensitivity of these strains by
growth in individual culture (Figure 8B). The most sensitive strain
in a screen with 1187–1561 was orf19.2411::Tn5/orf19.2411. The
S. cerevisiae ortholog Sc-SYN8 (non-essential in S. cerevisiae)i sa
SNARE protein that functions in vesicle fusion [43]. 0136–0228
induced a strong growth defect in a tfp1 mutant, which has no
ortholog in S. cerevisiae, but is computationally predicted to encode
a V-type ATPase that regulates intracompartmental pH. Because
its best BLAST hit is Sc-TFP1 and because these two genes share a
fungal orthogroup [44], we surmise that they also share function.
Consistent with an effect on intracompartmental pH, many of the
mutants most sensitive to this compound are also sensitive to
nigericin (vesicle transport related ORFs: TFP1, BTS1, orf19.2078,
orf19.880, orf19.6558, and others: orf19.9, FAA21, SPT5, and
orf19.6435). As noted above, it is likely that the genes disrupted in
nigericin-sensitive strains are interacting synthetically with defects
caused by altered intracompartmental pH.
We then performed a genetic test to see if 0316–0028 may
interact with Tfp1p. We overexpressed C. albicans Tfp1p in a wild-
type S. cerevisiae BY4743 and an Sc-Dtfp1 homozygous null mutant
background. Because we saw no effect with wild-type S. cerevisiae
(Figure 8C), we also tested an Derg6 null mutant to account for the
possibility that the compound was not penetrating the cell.
Deletion of ERG6 has been shown to increase compound
penetration due to defects in the cell membrane and has been
used to sensitize S. cerevisiae to brefeldin A [42]. First, we observed
that Tfp1p overexpression ameliorated the growth defect of the
Dtfp1 null mutant (and interestingly, also the Derg6 null mutant)
even in the absence of drug. This is consistent with results that
show that Sc-ERG6 and Sc-TFP1 interact synthetically [45].
Second, when strong growth inhibition was applied with 0136–
0228, we observed partial rescue of the growth defect in both the
Dtfp1 and Derg6 backgrounds, most distinctly in the drug-sensitized
Derg6 background (Figure 8C). That we observed rescue in a
heterologous system is strong evidence that this protein is a
functional target of this compound, and the fact that 0136–0228
also inhibits the Dtfp1 null suggests that it has additional targets in
the cell. We thus propose that Tfp1p is a principal protein target of
0136–0228, and that the other sensitive strains in its chemoge-
nomic profile appear as a secondary consequence of altered
intracompartmental pH (see Discussion). Haploinsufficiency
Figure 6. Several compounds have different inhibitory activity
in C. albicans versus S. cerevisiae. (A) Comparison of compound
inhibition between S. cerevisiae and C. albicans. Wild-type S. cerevisiae
(HO-1) and wild-type C. albicans (BWP17) were grown in YPD +1%
DMSO (control) or with one of 1521 unique chemical compounds. A
growth rate ratio was calculated by averaging 12 controls per 96-well
plate and dividing that by the drug-treated growth rate. Highlighted in
red are 40 compounds that inhibited C. albicans more than S. cerevisiae
(measured by difference in growth rate ratio). (B) Representative dose
response curves for compounds with different levels of inhibition
between S. cerevisiae and C. albicans. X-axis represents drug concen-
tration/dilution: initially 2 mL of compound of stock concentration was
diluted into 100 mL of YPD, then compounds were serially diluted across
the plate so that the final concentration was 1/64
th of that at the start.
Growth rate ratio is as described in (A). Wild-type S. cerevisiae dose
response curve are in black; wild-type C. albicans dose response curves
are in red. Compounds labeled xxxx-xxxx are synthetic, previously
uncharacterized chemicals (Chemical Diversity Labs, Inc.); 5-fluorour-
idine and brefeldin A are well-characterized compounds.
doi:10.1371/journal.ppat.1001140.g006
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view of the fitness profiles for 25 compounds. Z-scores for each of 3573 strains were calculated by comparing the intensity values for each strain
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reveal these gene-compound interactions (Figure 8A).
Discussion
Experimental multiplexing using DNA tags was one of the
essential attributes of the pioneering S. cerevisiae deletion collection,
enabling high-throughput genome annotation, genetic analysis,
and antifungal discovery [14,17,46]. A publically available,
archived, tagged mutant collection for C. albicans has the potential
to similarly accelerate research and drug discovery in an organism
directly relevant to public health. Using tagged transposon
mutagenesis, we constructed a tagged C. albicans mutant collection
that is fully sequenced identified and archived as individual
mutants. We note that our collection has some caveats. First, our
mutants were created in the –Arg –Ura –His strain BWP17 and so
remain auxotrophic for uracil and histidine. Synthetic effects with
these auxotrophies could produce false positives in some screens
and follow-up assays. In such cases, complementation of HIS1 and
URA3, or validation of the phenotype in an alternative strain
background can verify the phenotype. Our results sampling for
haploinsufficiency in an alternatively constructed strain both
supports that our results in BWP17-derived strains represent true
positives and also suggests that there are subtle but detectable
synthetic effects contributed by these auxotrophies. A second issue
is that because these strains are transposon mutants, they are not
likely to represent complete loss of function alleles. This latter case
has the advantage that multiple insertion events with different
degrees of functional disruption can be interrogated for a
particular gene. The other advantage is that this approach is
scalable. We report the creation of 4239 uniquely tagged gene
disruptions, representing 68% of 6197 predicted ORFs. Additional
mutagenesis can be used to create additional mutants, or, given
their compatibility, the TagModules can be integrated into
deletion cassettes to create the remaining mutants via homologous
recombination.
There are many potential applications of a C. albicans collection;
here we investigated haploinsufficiency, the phenomenon in which
a single gene copy in a diploid organism results in a fitness defect.
We applied the tagged mutant collection in a competitive growth
assay to identify haploinsufficient genes in four different nutrient
conditions, identifying 269 haploinsufficient genes across four
media conditions. This dataset represents a resource for further
study of their involvement in growth, morphogenesis, and
potential druggable targets. We found that C. albicans has a unique
profile of haploinsufficient genes, highlighting the importance of
niche (or C. albicans)-specific processes for maintaining wild-type
fitness. For example, C. albicans relies more heavily on oxidative
metabolism, nutrient sensing (e.g., permeases and nutrient
scavenging mechanisms), and resistance to oxidative stress for
optimal growth. Consistent with this observation, the host immune
response via neutrophils and macrophages involve superoxide
production to kill C. albicans [47], suggesting that these protective
mechanisms may be necessary for full growth. Moreover,
dependence on oxidative metabolism is consistent with a
requirement for efficient energy production for rapid growth.
Because it has evolved within a human host, C. albicans may rely
more heavily on oxidative metabolism, because carbon sources in
the form of fat or proteins may be more accessible than simple
sugars. Metabolites of both fat and proteins are shunted into the
tricarboxylic acid (TCA) cycle as acetyl-CoA for subsequent
breakdown in oxidative phosphorylation. Consistently, we found a
predicted fatty acyl-coA synthetase (FAA21) haploinsufficient in 3
conditions. Targeting C. albicans-specific metabolic processes may
be a useful approach for identifying novel antifungals.
We identified several transcription factors as haploinsufficient in
C. albicans, a notable distinction from S. cerevisiae, suggesting that
transcriptional regulation may be less flexible in C. albicans with
heterozygous alleles manifesting haploinsufficiency. One possible
explanation for this observation is that C. albicans is less tolerant of
changes in gene dosage as it generally exists in a diploid state. In
contrast, S. cerevisiae exists as both a haploid and a diploid, and so
these changes in dosage can be tolerated without a reduction in
fitness. A second possibility is that because C. albicans is an obligate
diploid that lacks a traditional meiotic cycle, two alleles of a
transcription factor have diverged such that they are no longer
functionally equivalent. This is supported by extensive allelic
heterozygosity observed during assembly of the C. albicans genomic
sequence [48]. Functional allelic variation has also been observed
in C. albicans in a number of small-scale studies, for example in
drug pumps [49], or for HWP1, in which the two alleles are
differentially expressed under biofilm conditions [50].
We next used our dataset to identify which genes function in
core cellular processes, and which are haploinsufficient in a
specific nutrient condition. Selecting from candidates generated
through genome-wide screens, we followed up on a subset of 17
genes from a ‘‘core’’ set of 70 haploinsufficient genes using
complementation testing and individual strain growth analysis.
Although complementation testing in S. cerevisiae is an imperfect
test of function, it is useful for generating hypotheses that can be
used to infer function for the remaining uncharacterized genes in
the ‘‘core’’ dataset of putative essential genes. We found that 10 of
these 17 genes were able to complement their essential S. cerevisiae
ortholog, strongly suggestive of functional similarity for these
conserved processes. For those genes that did not complement, it is
possible that their phenotypes arose from the influence of strain
auxotrophies. Alternatively, failure to complement can also result
from result of alternative codon usage in C. albicans. Interestingly,
we found that both complementing and non-complementing genes
contained the alternative CUG codon (Table 2)).
We also identified a set of genes necessary for growth in
nutrient-limiting conditions, and found that while necessary for
growth in limited nutrients, these genes were generally not
necessary for filamentation. As filamentation in fungi is a well-
documented response to low-nitrogen conditions (presumably an
adaptation to improve nutrient acquisition) [51], we anticipated
that filamentation might play a role in growth in nutrient-limited
conditions. Contrary to this expectation, our results suggest a
disconnect between growth rate (which may require optimal
nutrient utilization) and filamentation (which may require specific
under 20 generations of compound treatment to a no-drug control set. The dot plot distribution of the z-scores is useful in identifying outliers for
each compound treatment. These 25 compounds represent the 44% of those tested that resulted in a small number of significant outliers. The most
sensitive strain for each screen (highlighted in red) is listed on the right. (B) Comparison of haploinsufficiency in S. cerevisiae and C. albicans for
nigericin and brefeldin A. Z-scores for S. cerevisiae were calculated as for C. albicans, except only the 1150 essential heterozygotes of S. cerevisiae
genes were screened. Top, chemical structures of these two compounds. Bottom, dotplots of the z-scores calculated for the chemical treatments,
which were screened in the pooled growth assay at a concentration that produces ,10% inhibition of wild-type. Strains marked with a red triangle
are those involved in Golgi vesicle transport. Unlabeled leftmost red triangles for nigericin (C. albicans) represent orf19.6558, orf19.2078, and TFP1,
orf19.1265 (from left).
doi:10.1371/journal.ppat.1001140.g007
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PLoS Pathogens | www.plospathogens.org 12 October 2010 | Volume 6 | Issue 10 | e1001140Figure 8. 0136–0228 and 1187–1561 also inhibit vesicle transport in C. albicans. (A) Comparison of haploinsufficiency in S. cerevisiae and C.
albicans for two Chemical Diversity Lab compounds, 1187–1561 (top) and 0136–0228 (bottom); description is as in (B). Leftmost red triangles in 0136–
0228 (C. albicans) represent, from left, orf19.1376, orf19.6558, orf19.2078, and orf19.645.1. (B) Single strain growth curves for control (1% DMSO) and
drug-treated TFP1 (0136–0228), right, and SYN8 (1187–1561), left. Wild-type C. albicans (BWP17) is included as a control for both plots (black & blue).
(C) Overexpression of Tfp1p in a heterologous system alleviates growth defects resulting from treatment with 0136–0228. S. cerevisiae strain
background is marked in the upper left corner. TFP1 was cloned into an S. cerevisiae 2 micron expression vector under a constitutive GPD promoter
(pAG426GPD, [60]). Overexpression clones were then transformed into one of the three S. cerevisiae backgrounds (wild-type BY4743, a Dtfp1 null, or a
drug-sensitive Derg6 null) and grown in the presence (18.3 mM, red) or absence (1% DMSO, blue) of 0136–0228. As a control, an empty pAG426GPD
plasmid was transformed and grown in parallel (black, green).
doi:10.1371/journal.ppat.1001140.g008
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biological perspective, filamentation may be the preferred lifestyle
for tissue invasion or macrophage evasion in which the ability to
grow rapidly is less important. C. albicans cells that are unable to
filament in vivo are avirulent, and null mutants of EFG1,a
transcriptional regulator of filamentation, have normal growth
[52]. However, whether all mutants that have a filamentous defect
display wild-type growth has not been systematically determined.
From the standpoint of developing new treatment strategies,
identifying both fungicides, which can be identified by growth
inhibition screens, and inhibitors of pseudohyphal growth are of
value. With the appropriate experimental design, both types of
screens can be performed with this collection, as we have
exemplified by preliminary results from a SLAD solid media
pooled experiment.
We also investigated drug-induced haploinsufficiency in C.
albicans, screening the pool with compounds that were most likely
to produce a differential drug response by selecting compounds
that more potently inhibited C. albicans than S. cerevisiae.
Interestingly, we observed that the same chemical inhibitor can
have different effects in S. cerevisiae and C. albicans. For instance,
wild-type S. cerevisiae is much less sensitive to nigericin or brefeldin
A than wild-type C. albicans, and mutants with the highest
sensitivity in screens with these compounds did not include Sc-
SEC7. This suggests that; 1) other targets in S. cerevisiae have a
greater impact on S. cerevisiae’s sensitivity to brefeldin A and
nigericin, 2) that the drug is detoxified in S. cerevisiae, or 3) that C.
albicans has less genetic redundancy for the pathways inhibited by
these compounds. We also identified two other synthetic,
previously uncharacterized compounds that inhibited vesicle
transport in C. albicans, 0136-0228 and 1187–1561. Interestingly,
the sensitivity profile of 0136–0228 overlapped that of nigericin,
although their chemical structures show no obvious similarity.
This result can be explained if 0136–0228 inhibits Tfp1p, a
putative V-type ATPase that regulates intracompartmental pH
[53]. Support for this scenario came from our complementation
experiments, in which the drug-induced growth defect was rescued
by overexpression of Tfp1p in S. cerevisiae. Abrogation of
intracompartmental pH regulation via disruption of ion flow
across vesicle membranes likely results in growth defects similar to
those produced by nigericin, which produces a similar disregula-
tion of intracompartmental pH. Interestingly, no orthologs or
proteins of similar function were found in S. cerevisiae screens with
this compound, again underscoring the need for direct study of C.
albicans to identify novel treatment strategies.
The approach of using tagged transposon mutagenesis to
generate mutant collections can be applied to a wide range of fungi
of medical interest. The in vitro mutagenesis method allows
flexibility because organism-specific transposons are not required,
although a means for homologous recombination is needed.
However, this approach could also be adapted to an in vivo format
if the transposon could be electroporated directly into the cell (e.g.,
using commercially available transposome technology [54]), or if it
could be expressed endogenously. Both of these approaches could
bypass the transformation step, although they may be subject to
insertion bias. Additionally, the TagModules can be readily
adapted to a targeted deletion system for fungi with a compatible
recombination system. While model organisms such as S. cerevisiae
have been invaluable in initiating research in a range of
microorganisms of medical interest, ultimately, it will be most
fruitful to identify novel treatment strategies using the pathogen
itself, owing to pathogen-specific differences. In summary, we have
generated a uniquely tagged, publically available and archived
disruption collection in C. albicans that can be used in multiplexed
phenotypic assays or in individual experiments to identify potential
new biology, therapeutic targets and mechanisms of pathogenesis.
Methods
All primers, plasmids, and strains are detailed in Tables S9, S10, and
S11. Additional details are available on the supplementary website
(http://chemogenomics.med.utoronto.ca/supplemental/transposon/)
and as a text file (Methods S1). GO analysis (http://www.
candidagenome.org/cgi-bin/GO/goTermFinder) was performed be-
tween 01/2010-02/2010.
Library construction
C. albicans genomic DNA was isolated from strain BWP17
(ura3D:: l imm434/ura3D::limm434 his1::hisG/his1::hisG arg4::hisG/
arg4::hisG) [55] and partially digested with one or more of the
following enzymes: XbaI, EcoRV, SpeI, XbaI/SpeI, XbaI/
EcoRV, or BsrBI. The partially digested DNA fragments were
gel purified to approximately 2–8 kb in size and ligated into a
library backbone cut with the corresponding enzyme and
phosphatase-treated. Backbones used were pCR 8/GW/TOPO
+ linker for XbaI, EcoRV, and BsrBI-cut genomic DNA, and
pUC19 + linker for SpeI, XbaI/EcoRV, and SpeI/XbaI-cut
genomic DNA. Construction of these vectors was previously
described [27]. Each library contained on average 20,000 clones.
We also used a commercially available C. albicans genomic library
(Open Biosystems; [56]).
Transposon mutagenesis
The transposon destination vectors Tn7-UAU1-A and Tn5-
UAU1-C.1, modified from Tn7-UAU1 [21] and EZ-Tn5 pMOD-3
(Epicentre Biotechnologies) to contain the Gateway recombination
sites, were obtained from our previous study [27]. The Gateway-
compatible TagModules [27] were pooled and transferred to the
Tn7-UAU1-A or the Tn5-UAU1-C.1 vectors as previously
described [27], and the resulting tagged transposons were used
in the mutagenesis of C. albicans genomic libraries as described in
the same study. The majority of insertions were generated using
the Tn5-UAU1 due to technical difficulties with the Tn7. Each
insertion was sequenced using D2_revcomp (Tn7-based) or U1
(Tn5-based) to identify the gene disrupted and the tag associated
with each disruption. Gene-tag pairs were sorted to maximize i)
the number of unique TagModules, ii) unique gene mutagenesis
events, and iii) highest % gene disrupted (# base pairs from
transposon junction to gene start)/(total gene length). Overall
genome coverage is represented in Figure S1. Select insertion
plasmids were then plasmid prepped with Seqprep 96 (Edge
Biosystems), and the genomic fragment containing the tagged
insertion was excised with the appropriate enzyme and chemically
transformed into BWP17 in 96-well format.
At this step, two pools were created, one with unique uptags and
one with unique downtags (for details, see Figure S2 and Methods
S1; for pool characteristics, see Table S1). We separately arrayed
transformants for each pool to agar plates and scraped the colonies
into SC- Arg + uridine +15% glycerol to create the C. albicans
pools, which we then stored as 50 mL aliquots at 280uC. For
validation, we grew the pools independently in YPD for 20
generations as described in [34] minus the 10-generation recovery
time, and extracted genomic DNA using the YeaStar Genomic
DNA Kit (Zymo Research). PCR amplification of the uptags and
downtags was performed separately with the common primers U19
& BTEG-U29, and D19 & BTEG-D29, and 30 mL each of uptag
and downtag product was hybridized to an Affymetrix TAG4
microarray as described [57].
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For haploinsufficiency experiments, YPD, SC – Arg + uridine,
YNB + uridine, and SLAD + uridine were made as defined in
[58]. Growth assays were performed in duplicate in each of the
media conditions, and samples were recovered at 5, 10, 15, and 20
generations of growth. Genomic DNA extraction, tag amplifica-
tion, and hybridization were performed as described above. In
total, we performed a series of eight hybridizations per media
condition plus two hybridizations for a common zero timepoint.
For the zero timepoint, ,2O D 600 of frozen cells were used as the
cell template for the genomic extraction.
For array data pre-processing, we followed the protocol outlined
in [57,59]. Briefly, outliers were masked and removed, and the
average of the unmasked replicates were calculated for each tag.
Uptags and downtags were mean-normalized, and low-quality tags
(those below 3X background intensity units) were removed. To
identify strains with reduced fitness in each of these growth
conditions, we used a linear regression model to track decreases in
tag hybridization intensity as a function of time. Linear regression
of the log2(tag intensity) as a function of generations of growth (0,
5, 10, 15, and 20) was implemented using the lm() function in the
statistical program R. A negative regression slope indicates that the
tag signal decreases over time, inferring that the strain has a fitness
defect in this condition with respect to the pool as a whole. To
correct for multiple testing, the p-value for each regression was
adjusted using the false discovery rate (‘‘fdr’’) option of the R
function p.adjust(). For comparisons of regression slope between
media types, an F-statistic was calculated and a p-value derived
from the distribution. Our criteria for strain sensitivity was slope
,0, p,0.05. This is a slightly less stringent cutoff than reported in
Deutschbauer et al. (2005) as we have observed that the
competitive growth assay is capable of detecting even slight
defects in growth.
Complementation testing
For complementation testing, we used several pre-existing S.
cerevisiae resources for the strain background. We picked individual
strains from the Magic Marker collection (Open Biosystems, [32])
of yeast heterozygous deletions containing the selectable matA
haploid marker. As the Magic Marker strains have some reversion
rate, as evidenced by some colonies observed on the no-vector
plates, we confirmed a few of these results with traditional tetrad
dissection of the sporulated yeast knockout (YKO) strain, which
has no Magic Marker cassette. For overexpression, we used as our
destination vector the Gateway compatible destination vector
pAG416GPD-ccdB (Addgene, [60]), which is a Ura+ CEN
plasmid under control of a constitutive promoter.
For cloning C. albicans ORFs, we PCR amplified approximately
500 bp up and downstream of the start codon using primers
specific to each gene and Platinum PCR SuperMix High Fidelity
Primer Solution (Invitrogen). PCR products were TOPO cloned
into the Gateway entry vector pCR 8/GW/TOPO (Invitrogen).
Individual clones were sequenced using primers GW1 and GW2.
Correct clones were then transferred to the pAG416GPD-ccdB
destination vector using the LR clonase reaction (Invitrogen), and
resequenced as described. For S. cerevisiae overexpression plasmids,
we picked clones from the Molecular Barcoded Yeast (MoBY)
ORFs (Open Biosystems, [61]). As these were already Gateway
compatible, we transferred them to the overexpression plasmids
using the LR clonase reaction and sequence verified them using
primers GPD_ProF and pBluescriptSK.
Overexpression plasmids were chemically transformed into the
corresponding Magic Marker or YKO strain, selecting for Ura+
transformants. Individual colonies were then inoculated to SC –
Ura and grown overnight. Cultures were then harvested, washed
twice with water, and then resuspended in sporulation media (2%
potassium acetate) at a density of 1–1.5 OD600/mL. After
sporulation for 5 days, 4.5610
24 OD600 of sporulated Magic
Marker culture was plated to Magic Marker selection media –Ura
and grown for 2–3 days at 30uC. YKO-based strains were tetrad
dissected and plated onto SC –Ura + G418. Tetrad dissected
plates were then replica plated onto 5-FOA and YPD + G418 agar
plates to confirm complementation.
Individual growth experiments
For individual growth experiments, we picked mutants from the
frozen stock and grew them to saturation in SC –Arg + uridine.
Each strain was then diluted to a working OD600 of ,0.6 in water.
For 5 generation experiments, each strain was diluted to a final
OD600 of 0.06 in YPD, SC –Arg + uridine, YNB, or SLAD in 96-
well plates. For 20 generation experiments, each strain was diluted
to a final OD of 0.03 in the media of interest in 48-well plates, and
growth was measured every 15 minutes robotically diluting every 5
generations as in the pooled growth assay. To measure growth of
the GRACE strains, 12 of 17 of the core haploinsufficient strains
identified in our screens were obtained as GRACE alleles (5 were
not constructed), in which heterozygotes were constructed such
that the remaining allele is under the control of a tetracycline-
repressible promoter [33]. 400 cells of each strain (as determined
by hemocytometry) were inoculated into 650 mL of media in 48-
well plates (Greiner) and grown with constant shaking at 30uCa s
described [57]. In these conditions, individual cultures underwent
,14 generations of growth without necessitating re-inoculation
during the course of the experiment. Each strain was assayed in
triplicate in selective SC –Arg + uridine media in the presence or
absence of the tetracycline analog doxycycline (100 mM). AvgG (a
metric of growth) was calculated as previously described [34].
Test for filamentation on solid media
Individual strains were picked from the frozen stock and grown
overnight in SC –Arg + uridine. Strains were then stamped in
triplicate to Spider agar media and grown for 5 days at 30uC, and
colonies were then examined microscopically for filamentation.
Methods for the pooled assay on solid SLAD media are described
in Methods S1.
Drug screening
A diversity library was obtained from ChemDiv, Inc. and
dissolved in DMSO. Other compounds were obtained from Sigma
with the exception of itavastatin ca (Sequoia Research Products)
and enantio-paf C-16 (Enzo Life Sciences). Each compound had
previously been titrated to an inhibitory level of ,10% in S.
cerevisiae in YPD buffered to a pH of 6.8 with HEPES [62]. We
grew C. albicans strain BWP17 and S. cerevisiae strain HO-1 in the
presence of these 1521 distinct compounds under the same
conditions, measuring AvgG as previously described [34].
Titration experiments were performed in microtitre plates,
growing BWP17 and HO-1 in 100 mL buffered YPD plus either
1% DMSO (control) or 2 mL of compound at stock concentration.
Growth rate in compound dilutions of up to 1/64
th original
concentration (or further, if necessary) were measured as
previously described. AvgG from each microtitre plate was
normalized to the 12 controls on each plate.
Selected compounds were then chosen for follow-up in dose
response and pooled growth assays. First, compounds were ranked
in order of greatest difference in inhibition between C. albicans and
S. cerevisiae (D(normalized AvgG)). As a number of the compounds
which produced the greatest difference in inhibition were not
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pooled growth assay failed, we focused on ,67 available
compounds for follow-up. The majority of these produced greater
inhibition of C. albicans in the dose response assays (Figure S6). For
pooled growth assays with 57/67 of these compounds, 20-
generation pooled growth assays were performed as described
[34,62]. To determine sensitive strains, the experimental array was
compared to a matched control set comprised of 11 no-drug arrays
[18]. We then calculated z-scores and associated p-values as a
metric of sensitivity as described [18].
Supporting Information
Methods S1 Supplementary methods.
Found at: doi:10.1371/journal.ppat.1001140.s001 (0.07 MB
DOC)
Figure S1 Multiple genomic libraries are necessary to improve
genome coverage. (A) Transposon insertion sites are plotted by
coordinate organized by chromosome. We used one commercial
library (blue) and constructed a total of six genomic libraries.
Green: genomic DNA was digested to completion with XbaI,
yellow: SpeI, black/cyan: genomic DNA was partially digested
with XbaI/SpeI or XbaI/EcoRV; red: remaining libraries were
generated by digestion of genomic DNA with either EcoRV or
BsrBI. The majority of mutants were generated using either XbaI-
or SpeI-generated genomic libraries. (B) Close-up of terminal
region of chromosome 8; colors are as in (A).
Found at: doi:10.1371/journal.ppat.1001140.s002 (0.96 MB TIF)
Figure S2 Scheme and validation for using one tag per strain.
(A) Unique uptags were selected for one pool and unique downtags
for a second pool, overall representing 4401 strains (4388 unique
genes). The two pools are then screened and tags amplified in
parallel to prevent cross-contamination of overlapping tags. The
uptag and downtag PCRs can then be combined prior to
hybridization. (B) Validation of the one tag per strain approach
outlined in Figure S2A. Two uniquely tagged pools were used to
increase the number of strains able to be represented on an array.
Hybridization performance of the pool was compared to see if
strain tracking was affected depending on whether the uptag or a
downtag was used to represent a strain. Two independent pools
(‘‘pool 1’’ and ‘‘pool 2’’) of the 4252 successfully transformed
strains were grown for 20 generations in YPD +1% DMSO.
Uptags were amplified from pool 1, and downtags from pool 2,
and hybridized to a TAG4 array. In a ‘‘tag swap’’, downtags from
pool 1 and uptags from pool 2 were then amplified and hybridized
to an array. Pearson correlation of tag intensities above 3X
background is indicated in the upper left corner.
Found at: doi:10.1371/journal.ppat.1001140.s003 (0.71 MB TIF)
Figure S3 Cross-hybridization of tagged strains to unused tags.
Distribution of log2 tag intensities of the remaining 12686
unused tags on the array. Log2 of background intensity = ,6;
cutoff for detection was 3X background (log2 = ,7). 394 tags
were above 3X background; 166 corresponded to repaired tags
[6], which have significant sequence similarity to other tags, 116
with no sequence similarity, and 112 corresponded to unused
TagModules.
Found at: doi:10.1371/journal.ppat.1001140.s004 (0.27 MB TIF)
Figure S4 Confirmation of haploinsufficient phenotype with
GRACE strains. (A) The 17 ‘‘core’’ strains were monitored for
growth over 20 population doublings in a microplate reader in
triplicate, with representative curves shown. Every 5 generations,
cells were robotically transferred to a well containing fresh media.
Growth data from the 2nd (,10 generations), 3rd (,15
generations), or 4th (,20 generations) transfers was plotted against
time (for some mutants, 15 or 20 generation growth data was not
available). In all plots, black represents wild-type BWP17; each
plot represents the mutants grown in a single plate with its own
wild-type control. All curves were grown in selective SC media. (B)
The 12 GRACE strains [8] were grown in selective SC media over
,10–15 generations of growth. In (C), these mutants were grown
in the presence of 100 mM doxycycline. In (D), the mean of
triplicate AvgGs as percentage of wild-type growth were calculated
for each curve. As growth curves in (A) were performed via robotic
transfer, we were unable to calculate AvgGs for these curves.
Found at: doi:10.1371/journal.ppat.1001140.s005 (1.21 MB TIF)
Figure S5 Additional complementation tests of C. albicans ORFs.
Description is as in Figure 4. All negative results with the Magic
Marker strains (top round panels) were confirmed by tetrad
dissection (representative tetrads are in bottom rectangular panels,
if applicable). Top panel (round plates): left, negative control
(vector-only); center, complementation with C. albicans ORF; right,
positive control (complementation with corresponding S. cerevisiae
ORF). Bottom panels (rectangular): all tetrads were replica-plated
onto media containing 5-fluoroorotic acid (5-FOA) or geneticin
(G418) to confirm that the overexpression clone was the source of
complementation. First row: the tetrad dissection (left is negative
control (vector-only); center, complementation with C. albicans
ORF; right, positive control (complementation with corresponding
S. cerevisiae ORF)). Second row: replica plate to 5-FOA; third row:
replica plate to geneticin (G418).
Found at: doi:10.1371/journal.ppat.1001140.s006 (9.80 MB TIF)
Figure S6 Additional dose response curves. Description is as in
Figure 6.
Found at: doi:10.1371/journal.ppat.1001140.s007 (1.44 MB TIF)
Figure S7 Chemical structures of compounds screened in the
pooled growth assay.
Found at: doi:10.1371/journal.ppat.1001140.s008 (2.74 MB TIF)
Figure S8 Distribution of pair-wise compound similarity.
Compound similarity was calculated based on an ECFP_4
representation of each compound and scored with the Tanimoto
coefficient. The distribution for the 57 compounds screened is
shown in red. A random set of 57 FDA compounds (blue) is also
shown as a comparison. Both sets of compounds are structurally
diverse, as the pair-wise similarity is lower than the widely used
threshold of 0.3 to define diversity when ECFP_4/Tanimoto is
used [9].
Found at: doi:10.1371/journal.ppat.1001140.s009 (0.30 MB TIF)
Table S1 Summary of C. albicans mutants created
Found at: doi:10.1371/journal.ppat.1001140.s010 (0.02 MB XLS)
Table S2 List of heterozygous disruption C. albicans mutants
generated in this study
Found at: doi:10.1371/journal.ppat.1001140.s011 (1.25 MB XLS)
Table S3 Regression slopes and adjusted p-values for all strains
Found at: doi:10.1371/journal.ppat.1001140.s012 (1.09 MB XLS)
Table S4 Genes haploinsufficient in all conditions
Found at: doi:10.1371/journal.ppat.1001140.s013 (0.03 MB XLS)
Table S5 Genes haploinsufficient in 3 or more conditions
Found at: doi:10.1371/journal.ppat.1001140.s014 (0.04 MB XLS)
Table S6 Genes haploinsufficient in hyphae-inducing conditions
Found at: doi:10.1371/journal.ppat.1001140.s015 (0.04 MB XLS)
Table S7 Z-scores and p-values for compound screens
Found at: doi:10.1371/journal.ppat.1001140.s016 (8.88 MB XLS)
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solid SLAD media
Found at: doi:10.1371/journal.ppat.1001140.s017 (0.09 MB XLS)
Table S9 Primers used in this study
Found at: doi:10.1371/journal.ppat.1001140.s018 (0.03 MB XLS)
Table S10 Strains used in this study
Found at: doi:10.1371/journal.ppat.1001140.s019 (0.03 MB XLS)
Table S11 Plasmids used in this study
Found at: doi:10.1371/journal.ppat.1001140.s020 (0.02 MB XLS)
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